To systematically review the association between breastfeeding and childhood allergic disease.
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Outcomes of interest were current symptoms or diagnosis (within the past 12 months) of the following allergy-related conditions: asthma, eczema, allergic rhinitis and food allergy.
Recent disease was defined as either recent symptoms or health-care utilisation for the respective allergy-related conditions. The acceptable criteria for outcome definitions were: 1) Asthma defined as: physician diagnosed asthma, parent or self-reported asthma or wheeze, spirometrically diagnosed asthma, or asthma recorded on health related databases.
2) Allergic rhinitis defined as: physician diagnosed allergic rhinitis/hay fever, parent or self-reported hay fever, or hay fever recorded on health related databases.
3) Eczema/Atopic dermatitis defined as: physician diagnosed eczema, parent or selfreported eczema, by validated eczema diagnostic criteria (e.g. UK working party, International Study of Asthma and Allergies in Childhood (ISAAC) survey), or eczema recorded on health related databases. 4) Food allergy defined as: physician diagnosed food allergy, parent or self-reported food allergy, by objective measures (serum IgE, skin prick testing, oral food challenge), or food allergy recorded on health related databases Two authors (DT and ML or XD) independently screened titles and abstracts of all identified records. Duplicates and multiple reports from the same study with the same outcomes were excluded. Studies assessed as eligible, potentially eligible or unclear were retrieved in fulltext where available, to assess for inclusion. Any disagreements either at this stage or further on in the process were settled by consultation with a third author (CL).
Data extraction
Study characteristics and outcomes were extracted from each included study by two authors working independently (DT and ML or XD) using a standard data collection form created for this purpose. Information extracted included: First author, date of publication; study design, number of study centres and location, study setting, date of study; number of participants, mean age, age range, gender, inclusion criteria, exclusion criteria; breastfeeding classifications; length of breastfeeding recall; outcome definitions; confounders and interactions; effect estimates and 95% CI.
Quality assessment / Risk of bias in included studies
Study quality was assessed independently by two authors (DT and ML or XD) using both the Newcastle-Ottawa scale (NOS) (23) for individual studies, (a design specific scale -crosssectional versus case-control versus cohort study) and the GRADE guidelines (24) to assess quality by outcome over a range of studies. Sources of bias were rated as high, low or unclear. NOS study quality was graded according to total score. Cohort and case-control studies: very good = 9-10; good = 7-8; satisfactory = 5-6; unsatisfactory = 0-4. Crosssectional: very good = 6-7; good = 5; satisfactory = 4; unsatisfactory = 0-3.
Data categorization
Studies were grouped according to type of breastfeeding exposure and then further grouped by age of outcome, nature of effect measure (e.g. Odds Ratio, Hazard Ratio, etc.) and study type. Final groups with three or more studies were suitable for meta-analysis. Breastfeeding categories included:
• Ever versus Never: children receiving breast milk at any time compared with those never breast fed.
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• More or Less than 3-4 months: children fed with breast milk up to 3-4 months compared to other feeding modes.
• More or Less. This category was created to include all studies which compared groups with relatively more and relatively less breast milk exposure. In order to choose between multiple available odds ratios for a single study we preferentially selected estimates for exclusive breast feeding, then longest duration versus shortest. If multiple ages of outcome were available we chose the oldest up to 18 years.
Prior to pooling, we stratified by age of outcome based on clinical knowledge of likely phenotypes. For asthma this was outcomes during childhood (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) and those in adulthood >18. For eczema, early childhood eczema/infantile eczema (<=2 years) and eczema > 2years.
Both allergic rhinitis and food allergy were stratified into outcomes before and after 5 years of age.
Analysis
Studies were considered suitable for meta-analysis if they provided an adjusted measure of the effect of breastfeeding on allergic outcomes with 95 % confidence intervals.
Heterogeneity of the pooled estimate was assessed using the I 2 statistic. If I 2 was below 25%, fixed effects were presented, if between 25 % and 75%, random effects (re) presented. If the I 2 was above 75%, we provided the pooled estimate, but considered it unreliable. Funnel plots were used to assess publication bias. Egger's tests were used to quantify small study effects when there were at least 10 studies in a pooled analysis. Substantial heterogeneity was explored through subgroup analysis using meta-regression if there were 10 estimates likely in each subgroup strata. The subgroups defined prior to the analysis included age of outcome assessment, category of breastfeeding exposure, year of study, birth year of participants, length of recall for breastfeeding exposure, type of study and income level. Income was
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Both of the studies that investigated the relationship between breastfeeding and asthma into adulthood found an increased risk (17, 43) . In the Tasmanian Longitudinal Health Study (TAHS), Matheson et al found an increased risk of asthma from the age of 14 to 44 years but only in children of atopic mothers who exclusively breastfed for at least 3 months. In the Dunedin cohort, Sears et al found an increased risk of asthma from the age of 9 to 26. This relationship was not modified by the allergic history of either parent.
The issue of reverse causation was addressed by four of the 42 studies. Two found no evidence (26, 29) , a third found a non-significant tendency to breastfeed longer for infants with early signs of eczema (37), and the fourth found some degree of reverse causation after exclusion of those with wheeze or eczema during the breastfeeding period (64).
Three studies addressed the association between breastfeeding and atopic asthma phenotypes. Breastfeeding was found to reduce the risk of asthma in non-atopic children in one study (27) and conversely to reduce the risk of asthma in atopic children in two studies (44, 64). Table 3) Investigation of potentially influential subgroups within these data found two factors of interest: length of recall of breastfeeding (which explained 29% of the between study variability) and year of the child's birth (which explained around 16%). In terms of the subgroup pooled estimates, there is evidence that some of the protective effect of breastfeeding on asthma may be related to recall bias in studies of lesser methodological quality. The cross-sectional and case-control studies were associated with a greater protective effect than cohort studies. Those studies with less adjustment for pertinent confounders and fewer participants also reported a stronger protective effect than those with good control and more participants.
Subgroup analysis by meta-regression (SI
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Eczema
The 42 records for eczema comprised 24 records from cohort studies (32, 37, 65-86), 17 from cross-sectional studies (48, 52-55, 59, 60, 87-96) and one case-control (97) . There were 26 studies from high income countries and 14 from middle/low income countries. Two studies presented multi-country data. The number of participants varied between 80 and 20,579 for the cohort studies and 470 and 206,453 for the cross-sectional studies (SI Table 6 ).
Study quality
Cohort studies were generally of good quality as determined by the NOS (range satisfactoryvery good) whilst cross-sectional studies were generally of satisfactory quality (range unsatisfactory to good) (SI Tables 3 , 4 & 5) . A common issue was failure to adjust for essential confounders including family history of allergic disease. Breastfeeding exposure measurement was also an area of weakness, relying on parental report and, especially in the cross-sectional studies, a period of recall which ranged from 1-20 years.
Synthesis of study findings
Studies were grouped into those reporting eczema up to or after the age of 2 years. There was a reduced risk of eczema below the age of 2 years from pooling the 6 cohort studies' estimates comparing exclusive breastfeeding greater than 3-4 months with other feeding types (re OR 0.74; 0.57,0.97, I 2 62%, Grade +) ( Fig 4) . There was some visual evidence of publication bias on the funnel plot, with more small studies showing a protective effect. (SI Fig 6) However, there was no association found between the risk of eczema up to 2 years for the exposure of more versus less breastfeeding (15 cohorts, 1 cross-sectional study)(re OR 0.95; 0.85, 1.07, I 2 =70 %, Grade ++) ( Fig 5) .
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After 2 years neither the ever breastfeeding, nor the more versus less exposures were associated with eczema. Ever versus never: 9 cross-sectional studies and one cohort study, re OR 1.07; 0.98, 1.16, I 2 =43%, Grade ++).(SI Fig 7) More versus less: 14 cross-sectional studies and 6 cohorts, re OR 1.09; 0.99, 1.20, I 2 86%, Grade +.(SI Fig 8) Although the more versus less category suggested weak evidence for an increased risk, the heterogeneity of the estimate was too high for the estimate to be reliable.
Pooled estimates from studies which investigated the association between breastfeeding and eczema by familial history of allergic disease did not find a different risk in the strata. (SI Fig 9) Reverse causation was explored by 5 out of 42 studies (37, 75, 77, 79, 84) with only one finding evidence of a non-significant tendency to breastfeed longer for children with early eczema symptoms (37). (Table 3) Age of eczema outcome explained 16 % of the variability between studies, with a lower risk found for children up to 2 years. Both the study design and length of breastfeeding recall were related to the pooled estimates, explaining 16% and 57% of the between study variability. Cohort studies and breastfeeding recall of up to 1 year were associated with lower pooled risk for eczema from breastfeeding, whilst increased length of breastfeeding recall and cross-sectional study design were associated with increased pooled risks. Additionally, lower pooled estimates for eczema risk were seen in middle/low income countries when compared to high income countries. The exclusive breastfeeding category was also associated with a lower eczema risk compared with both ever versus never and more versus less.
Subgroup analysis by meta-regression
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Allergic Rhinitis
The association between breastfeeding and allergic rhinitis was investigated by 5 cohort studies (31, 66, 98-100) and 11 cross sectional studies (48, 52-55, 59, 60, 96, [101] [102] [103] . The number of participants varied between 361 and 13,889 for the cohorts, and 1,402 to 206,453 for the cross-sectional studies. All except one study (98) were population based. (SI Table 7 )
Synthesis of study findings
Pooling of 12 estimates for more versus less breastfeeding without consideration of study type or age of outcome found a non-significant protective effect for allergic rhinitis: re OR 0.92; 0.84, 1.01, I 2 74%. (Fig 6) After stratification by age of outcome however, a reduced risk of allergic rhinitis associated with breastfeeding was found only below the age of 5 years from pooling 6 estimates (4 cross-sectional, 2 cohort): re OR 0.79 (0.63, 0.98), I 2 84%, Grade 0 (SI Fig 10) . Limiting to the 4 cross-sectional studies found a reduced heterogeneity and re OR 0.64, (0.64, 0.82), I 2 69%.(SI Fig 11) In contrast, there was no association or a nonsignificant increase in the risk of allergic rhinitis after 5 years from pooling 9 studies (5 crosssectional, 4 cohort): re OR 1.05 (0.99, 1.12), I 2 43%, Grade +. (SI figure 12 ) Analysis by study type, regardless of outcome age, found a reduced risk for 9 cross-sectional studies (re OR 0.88; 0.77, 1.00, I 2 77%) and no association for 3 estimates from cohort studies (re OR 0.99; 0.85, 1.15, I 2 78%). (Fig 6) One cross-sectional study found no interaction by parental atopy (101).
Food Allergy
There were 9 cohort (11, 17, 70, 79, 85, (104) (105) (106) (107) and 4 cross-sectional studies (101, (108) (109) (110) investigating the association between breastfeeding and food allergy. The numbers of participants in the cohorts ranged from 163 to 21,766, and from 1,278 to 13,110 in the cross-
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This article is protected by copyright. All rights reserved. sectional studies. Pooling of 12 estimates (6 cohort, 6 cross-sectional) for more versus less breastfeeding found no association with food allergy, although heterogeneity was very high (RE OR 1.02; 0.88, 1.18, I 2 86%). (Fig 7) After stratification for age of outcome, there was no association from pooling 12 estimates below the age of 5 years where heterogeneity was still too high for the estimate to be reliable (6 cohort, 6 cross-sectional) (re OR 1.07; 0.92, 1.24, I 2 85%, Grade+). (SI Fig 13) There was no association when the estimates from three cohort and one cross-sectional study were pooled for food allergy after the age of 5 years (re OR 1.08; 0.73, 1.58, I 2 65%, Grade+). (SI Fig 14) The only study that investigated the interaction of family allergic history on the association between breastfeeding and food allergy found the risk was increased only in those with a family history (OR 5.3; 1.2-24.1) (79) . This estimate should be interpreted with caution considering the very wide confidence intervals which reflect a small sample size (n=163). Furthermore, in their analysis, Kusunoki et al (110) demonstrated that the initial elevated risk of food allergy (defined by parent report of food reaction) in their data, associated with breastfeeding, was caused by reverse causation. There was no association when analyses were controlled for early disease symptoms and family history.
The main issue concerning the quality of studies on food allergy was the accuracy of outcome assessment. Most of the studies relied on parental report of symptoms or parental report of physician diagnosis. Only two studies used oral food challenge (107, 109) , the recognized gold standard for food allergy diagnosis.
DISCUSSION
We found evidence that breastfeeding reduced the risk of asthma in childhood and weak evidence for reductions in the risk of eczema up to 2 years and allergic rhinitis up to 5 years of age. There was no risk or protective association for food allergy. The Grade quality assessment for all these conclusions indicated an evidence confidence level of very low to low. As it is not possible to randomize breastfeeding exposure, our evidence comes only from observational studies (cohort, cross-sectional and case-control). The Grade ratings reflect this, as meta-analyses of observational studies are assigned an initially low rating, prior to further assessment of possible biases. The consistency of our results across three of the four allergic outcomes however may lend further credence to the findings. A lack of association with food allergy may be due to the delay in the food allergy epidemic, especially in studies from earlier times.
Asthma
Virally mediated early transient wheeze in younger children is a potential source of imprecision in asthma classification. Restricting this systematic review to asthma/wheeze outcomes from the age of 5 years, we found a reduced risk of asthma in childhood (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) years) associated with all categories of breastfeeding exposure. Exploring the moderate-high heterogeneity suggested that this risk reduction may be overstated, with more protective estimates contributed by studies of lower methodological quality in terms of study design and control of confounding. Further subgroup analysis in the Ever versus Never breastfeeding classification found that all the between study variability could be explained according to the income category of the countries, with breastfeeding in studies from middle/low income countries conferring more protection from asthma risk. This could not be confirmed when using the estimates for all breastfeeding categories.
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One mechanism which may explain a greater reduction of asthma associated with breastfeeding in middle/low income countries is through respiratory infections in childhood.
Not only are early life respiratory infections associated with early transient wheeze in young children, but they are also one of the strongest known risk factors for asthma in older children (111, 112) . Breastfeeding in early life is a known source of protection against early life infections (113) Due to the small number of studies reporting breastfeeding in early life and asthma in adulthood, we were unable to perform a meta-analysis. Although both studies investigating this association (17, 43) found an increased risk of asthma, their results were inconsistent concerning the role of family allergic history. Also, at least one of the studies was prone to breastfeeding recall bias (17) . These cohorts were both based in high risk, high income populations, and their findings are unlikely to be generalisable to populations with lower asthma risk and /or lower incomes.
In earlier systematic reviews and meta-analyses, Gdalevich et al (114) found a reduction in asthma risk in children exclusively breastfed for 3 months, especially in children
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Eczema and Allergic Rhinitis
For both eczema and allergic rhinitis, we found some low quality evidence of a reduced risk in early life (eczema ≤2years, allergic rhinitis ≤ 5years) associated with breastfeeding. For eczema, this was limited to exclusive breastfeeding for 3-4 months in cohort studies. After this age the protective effect of breastfeeding disappeared and there was weak evidence for an increased risk. Subgroup analysis found breastfeeding was associated with a greater eczema risk in studies of lower methodological design and longer recall of breastfeeding. These studies predominated in the pooled estimates for eczema over the age of 2 years. Although
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Breastfeeding seemed to confer greater protection against eczema in middle/low income countries, although this was not a significant source of between study difference. This observation may also be explained by protection from early life infections, if viral associated rash in infants is misdiagnosed as eczema. Alternatively, environmental differences may increase the risk of eczema in high income communities. Additionally, breastfeeding protection from allergic rhinitis in early life may also be explained by the difficulty of differentiating between allergic rhinitis and viral rhinovirus infections in very young children.
The reduced risk associated with breastfeeding in younger age groups could be attributed to the viral protection from breast milk rather than protection from allergic rhinitis.
With regard to systematic reviews on breastfeeding and eczema, an early study (20) found a reduced risk of eczema synthesizing 18 prospective studies in 2001. There was evidence of more protective effect in children at high-risk. A more recent systematic review and meta-analysis of 27 populations (116) however, also restricted to prospective cohort studies, found no strong evidence of a protective effect of exclusive breastfeeding for at least 3 months, even in children with a family history of allergy. Our finding of a protective effect for eczema below the age of 2 years in the exclusive breastfeeding group is novel, and suggests that breastfeeding may only be protective for the infantile eczema phenotype.
In a 2002 systematic review (21) , including 6 studies published between 1966 and 2000, exclusive breastfeeding was found to protect against allergic rhinitis in children with and without a family history of atopy. All of these studies assessed allergic rhinitis below the age of 5 years. Our findings are similar but extend this analysis to include 16 studies and to the over 5 age group where the diagnosis of allergic rhinitis may be less contaminated by viral rhinovirus infection.
Food Allergy
Breastfeeding was found to be neither a protective factor nor a risk factor for food allergy, however the number of records included was lower than those for other outcomes, limiting our ability to find associations and explore subgroups. The very high heterogeneity associated with the pooled estimates makes these values unreliable. Variability may be due to methodological differences including outcome definitions which in most cases did not include oral food challenge. It is difficult to explain why breastfeeding, in our review, appears to be protective for the 3 other common childhood allergic diseases but not for food allergy. Apart from the smaller number of studies and the inaccuracy of the outcome measurement, this may be explained by the relative delay in the food allergy epidemic and concurrent changes in breastfeeding guidelines that may have masked any association between breastfeeding and food allergy in the current studies. Alternatively, the current rise in food allergy in westernized countries may be attributable to different factors than other allergic diseases.
A systematic review on breastfeeding and food allergy (117) found a protective effect for cow's milk allergy in children at high risk with 4 months exclusive breastfeeding.
However, we must be cautious in drawing conclusions in highly select subgroups, especially when no main effects are observed.
Limitations
One of the challenges to finding solid evidence in this area is that all the available evidence is derived from observational studies (cohort, cross-sectional, case control), which have an inherent set of biases and inability to control for unknown confounders. Although studies exist involving randomization of groups to educational interventions for infant feeding (31), these studies advocate breastfeeding advice as one of a suite of measures making it difficult
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to attribute risk or protection to individual components.
Investigation of subgroups within the asthma and eczema outcomes found one of the important sources of between study heterogeneity was length of recall of breastfeeding. In both analyses, recall up to one year was associated with a greater reduction of allergic disease than breastfeeding recall of longer duration. Mothers with allergic children who made decisions to breastfeed longer may recall a longer breastfeeding history than mothers whose children are not allergic. This is an important source of potential recall bias which requires consideration when interpreting the evidence.
Reverse causation, namely the initiation or continuation of breastfeeding for reasons of familial allergy or early signs of allergic disease in the child, was explored in a minority of studies. It is possible that parents stop breastfeeding their children if there are early signs of allergic disease. This would be unlikely however considering the breastfeeding guidelines with regard to allergic disease (118) . Failure to account for reverse causation will underestimate the protective effect of breastfeeding on allergic disease. This may be part of the reason for the weak evidence of an increase in the risk of eczema and allergic rhinitis associated with breastfeeding in older compared with younger children. Very few of the included studies assessed reverse causation, and of those that did, only three found evidence that it may influence the relationship between breastfeeding and allergic disease (37, 64, 110). Nevertheless, this is something which should be considered in all studies. It is not clear why there are different findings concerning reverse causation, however recall bias may be an issue, and prospective collection of early allergic disease status with respect to breastfeeding practices is needed to assess this more accurately.
We found no evidence to support a greater positive or negative effect from breastfeeding if the infant had a family history of allergic disease. Meta-analysis of 6 asthma studies and separately 7 eczema studies that considered this issue, found no modification by
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In our review, by assessing all disease outcomes separately, we have discerned a pattern of reduction in early disease and no association or possible increase in adult disease.
Subgroup analysis raised the possibility that the increased risk in older age groups may be due to methodological issues related to length of breastfeeding recall, study type or date of study inception. Alternatively, risk reduction in younger age groups may reflect breastfeeding protection from early viral infections which can be either misdiagnosed as allergic disease (allergic rhinitis, eczema) or a potential mediator of allergic disease (asthma).
Another possibility is that breastfeeding may only be protective for early allergic disease phenotypes.
We were unable to comment on whether specific lengths of breastfeeding and/or exclusive breastfeeding would confer a greater reduction in allergic disease risk because of a lack of studies specifically addressing these issues.
CONCLUSION
There is weak evidence that breastfeeding, regardless of length or exclusivity, is protective for allergic disease. There is evidence of greater protection in middle/low income countries and no evidence that these associations were modified by an allergic family history. The protective effect for asthma, eczema, and allergic rhinitis appears to be greater in early life raising the possibility of mediation through protection from viral disease, misdiagnosis of viral disease, or effects only on specific phenotypes. There is weak evidence for waning protection or increasing risk in older children. Exploration of subgroups suggests that this effect may be partially mediated through bias induced by length of breastfeeding recall, or poorer methodology in earlier studies.
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More vs Less breastfeeding and the risk of wheeze/asthma 5-18 years by country income
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Odds Ratio
Breast feeding after 3-4months and the risk of eczema up to 2 years of age
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More vs Less Breast feeding and the risk of eczema up to 2 years of age
Odds Ratio
More vs Less Breast feeding and the risk of Allergic Rhinitis by studytype
